Live Breaking News & Updates on Coeptis Therapeutics Daily
Stay updated with breaking news from Coeptis therapeutics daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Coeptis Therapeutics (NASDAQ:COEP – Get Rating)‘s stock had its “buy” rating reissued by analysts at EF Hutton Acquisition Co. I in a research report issued to clients and investors on Wednesday, Benzinga reports. They currently have a $6.00 target price on the stock. EF Hutton Acquisition Co. I’s price objective indicates a potential upside of […] ....